Additionally, GLP-1 therapies are gaining recognition as a novel approach to Alzheimers disease due to their anti-inflammatory and neuroprotective characteristics
In contrast, the passive membrane permeation of small molecules and macrocyclic peptides is reasonably well developed and understood, to the point where computational models are now able to predict the permeability of small molecule drugs 6,7 and macrocyclic peptides with predominantly hydrophobic side chains 8 , especially when coupled with continuous constant p H molecular dynamics (C p HMD) models for small molecule drugs 6 (Fig
Ultimately, the decision to continue or discontinue GLP-1 treatment after reaching your weight loss goal should be based on a comprehensive assessment of your individual health needs, potential benefits, and any risks associated with long-term use of the medication
You can associate these side effects with specific doses, injection sites, nutrition, or hydration, making it easier to spot patterns and discuss them with your healthcare provider